BNKL OTC
Bionik Laboratories Corp.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$3M
+18.3% ▲
Capital Expenditures
$9K
+30.4% ▲
5Y CAGR: -16.6%
Free Cash Flow
-$3M
+18.6% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$2M
-213.1% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$11M | -$25M | -$14M | -$10M | -$5M |
| Depreciation & Amort. | $348K | $381K | $190K | $103K | $63K |
| Stock-Based Comp. | $1M | $2M | $819K | $438K | $377K |
| Change in Working Capital | -$1M | -$571K | $399K | $140K | $1M |
| Other Non-Cash Items | $1M | $177K | $406K | $6M | $106K |
| Operating Cash Flow | -$9M | -$9M | -$5M | -$4M | -$3M |
| — Investing Activities — | |||||
| Capital Expenditures | -$102K | -$160K | $0 | -$12K | -$9K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | -$215K |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$102K | -$160K | $0 | -$12K | -$224K |
| — Financing Activities — | |||||
| Net Debt Issuance | $9M | $0 | $3M | $6M | $2M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$3K | $11M | $0 | $0 | $0 |
| Financing Cash Flow | $9M | $11M | $3M | $6M | $2M |
| Net Change in Cash | -$61K | $2M | -$2M | $1M | -$2M |
| Cash End of Period | $447K | $2M | $608K | $2M | $427K |
| Free Cash Flow | -$9M | -$9M | -$5M | -$4M | -$3M |